Berjame, Angelita R.

HRN: 17-64-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFTRIAXONE 1G (VIAL)
05/30/2022
06/06/2022
IV
2grams
OD
Infected Wound, Right Foot
Waiting Final Action 
05/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2022
06/06/2022
IV
600mg
Q6hrs
Non Healing Wound, Right Foot
Waiting Final Action 
06/05/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/05/2022
06/12/2022
IV
4.5
Q6
HAP
Waiting Final Action 
02/09/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/09/2023
02/15/2023
IV
600mg
Q6
Breast CA, Left
Waiting Final Action 
07/12/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/12/2023
07/17/2023
IVT
600mg
Q6
Breast CA Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: